Back to calendar
Latigo Biotherapeutics, Inc. (LTGO) Earnings
LTGO reports earnings on Wednesday, September 2, 2026
earnings report
September 2, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.67
Actual EPS: $-2.23
Company overview
Market Cap$1.4B
PriceUSD 21.77
52-week high25.93
52-week low17.22
SectorHealth Technology
IndustryPharmaceuticals: Major